VolitionRX Ltd [AMEX: VNRX] surged by $0.01 during the normal trading session on Thursday and reaching a high of $0.5157 during the day while it closed the day at $0.45.
VolitionRX Ltd stock has also loss -25.47% of its value over the past 7 days. However, VNRX stock has declined by -33.75% in the 3 months of the year. Over the past six months meanwhile, it has lost -10.56% and lost -37.45% year-on date.
The market cap for VNRX stock reached $53.28 million, with 103.98 million shares outstanding and 79.03 million shares in the current float. Compared to the average trading volume of 275.54K shares, VNRX reached a trading volume of 4263432 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about VolitionRX Ltd [VNRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VNRX shares is $3.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VNRX stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for VolitionRX Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 08, 2025. The new note on the price target was released on February 01, 2023, representing the official price target for VolitionRX Ltd stock. Previously, the target price had yet another drop from $8 to $7, while Cantor Fitzgerald kept a Overweight rating on VNRX stock.
VNRX stock trade performance evaluation
VolitionRX Ltd [VNRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -25.47. With this latest performance, VNRX shares dropped by -28.32% in over the last four-week period, additionally sinking by -10.56% over the last 6 months – not to mention a drop of -25.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VNRX stock in for the last two-week period is set at 29.37, with the RSI for the last a single of trading hit 0.0525, and the three-weeks RSI is set at 0.0505 for VolitionRX Ltd [VNRX]. The present Moving Average for the last 50 days of trading for this stock 0.6236, while it was recorded at 0.4529 for the last single week of trading, and 0.6022 for the last 200 days.
VolitionRX Ltd [VNRX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and VolitionRX Ltd [VNRX] shares currently have an operating margin of -1779.01% and a Gross Margin at 2.71%. VolitionRX Ltd’s Net Margin is presently recorded at -1767.88%.
VolitionRX Ltd (VNRX) Capital Structure & Debt Analysis
VolitionRX Ltd (VNRX) Efficiency & Liquidity Metrics
VolitionRX Ltd (VNRX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, VolitionRX Ltd. (VNRX) effectively leverages its workforce, generating an average of -$274352.94 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.35% and a Quick Ratio of 0.35%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for VolitionRX Ltd [VNRX] stock
With the latest financial reports released by the company, VolitionRX Ltd posted -0.07/share EPS, while the average EPS was predicted by analysts to be reported at -0.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VNRX.
VolitionRX Ltd [VNRX]: Institutional Ownership
There are presently around $20.79%, or 24.99%% of VNRX stock, in the hands of institutional investors. The top three institutional holders of VNRX stocks are: LAGODA INVESTMENT MANAGEMENT, L.P. with ownership of 5.44 million shares, which is approximately 6.578%. VANGUARD GROUP INC, holding 0.64 million shares of the stock with an approximate value of $$0.39 million in VNRX stocks shares; and VANGUARD GROUP INC, currently with $$0.38 million in VNRX stock with ownership which is approximately 0.7676%.
